These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31028576)

  • 1. Shikonin Controls the Differentiation of CD4
    Zhang X; Li J; Yu Y; Lian P; Gao X; Xu Y; Geng L
    Inflammation; 2019 Aug; 42(4):1215-1227. PubMed ID: 31028576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin Prolongs Allograft Survival via Induction of CD4
    Zeng Q; Qiu F; Chen Y; Liu C; Liu H; Liang CL; Zhang Q; Dai Z
    Front Immunol; 2019; 10():652. PubMed ID: 30988670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
    Ni F; Huang X; Chen Z; Qian W; Tong X
    Sci Rep; 2018 Feb; 8(1):3317. PubMed ID: 29463831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Lck/Fyn kinase activity promotes the differentiation of induced Treg cells through AKT/mTOR pathway.
    Qin Z; Hou P; Lin H; Chen M; Wang R; Xu T
    Int Immunopharmacol; 2024 Jun; 134():112237. PubMed ID: 38744170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway.
    Zhang B; Yan G; Li F; Tang Y; Xu G; Zhang Y; Ze K
    Curr Pharm Des; 2024; 30(24):1927-1938. PubMed ID: 38835124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
    Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance.
    Shahine Y; El-Aal SAA; Reda AM; Sheta E; Atia NM; Abdallah OY; Ibrahim SSA
    Inflammopharmacology; 2023 Jun; 31(3):1341-1359. PubMed ID: 37010718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model.
    Lan XO; Wang HX; Qi RQ; Xu YY; Yu YJ; Yang Y; Guo H; Gao XH; Geng L
    Mol Med Rep; 2020 Sep; 22(3):2263-2272. PubMed ID: 32705251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding human T regulatory cells with the mTOR-inhibitor rapamycin.
    Battaglia M; Stabilini A; Tresoldi E
    Methods Mol Biol; 2012; 821():279-93. PubMed ID: 22125072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice.
    Xu L; Jiang Y; Xu F; Liu J; Jiang Y; Fang F; Luo L
    Int J Immunopathol Pharmacol; 2024; 38():3946320241260262. PubMed ID: 38876119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway.
    Xu Y; Xu X; Gao X; Chen H; Geng L
    Int Immunopharmacol; 2014 Apr; 19(2):327-33. PubMed ID: 24521871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
    Kurebayashi Y; Baba Y; Minowa A; Nadya NA; Azuma M; Yoshimura A; Koyasu S; Nagai S
    Biochem Biophys Res Commun; 2016 Nov; 480(1):114-119. PubMed ID: 27697523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation.
    Yu YJ; Xu YY; Lan XO; Liu XY; Zhang XL; Gao XH; Geng L
    Int Immunopharmacol; 2019 Jul; 72():511-521. PubMed ID: 31075711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of methotrexate on regulation for the number of regulatory T cells and expression of Foxp3 in psoriasis].
    Kuang Y; Zhang H; Zhu W; Wu L; Chen W; Lu Y; Qin Q; Jia X; Liao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 43(8):835-842. PubMed ID: 30197310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
    Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
    Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.